MedTrace Logo

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

NCT05705804 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2023-07-06

No results posted yet for this study

Summary

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.

Conditions

Interventions

DRUG

Pitavastatin

Pitavastatin 4 mg will be given.

DRUG

Pitavastatin plus Ezetemibe

Pitvastatin 4 mg plus ezetemibe 10 mg will be given.

DRUG

Atorvastatin

Atorvastatin 40 mg will be given.

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Byeong-Keuk Kim · Severance Cardiovascular Hospital, YONSEI UNIVERSITY COLLEGE OF MEDICINE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-13
Primary Completion
2025-02-28
Completion
2025-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05705804 on ClinicalTrials.gov